166 related articles for article (PubMed ID: 7768256)
1. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
Caraco Y; Zylber-Katz E; Berry EM; Levy M
Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
[TBL] [Abstract][Full Text] [Related]
2. Caffeine pharmacokinetics in obesity and following significant weight reduction.
Caraco Y; Zylber-Katz E; Berry EM; Levy M
Int J Obes Relat Metab Disord; 1995 Apr; 19(4):234-9. PubMed ID: 7627246
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine pharmacokinetics in obese and lean subjects.
Caraco Y; Zylber-Katz E; Berry EM; Levy M
Ann Pharmacother; 1995 Sep; 29(9):843-7. PubMed ID: 8547729
[TBL] [Abstract][Full Text] [Related]
4. The effect of fenfluramine on disposition and rate of antipyrine elimination.
O'Malley K; Stevenson IH; West M
Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
[TBL] [Abstract][Full Text] [Related]
5. Influence of a very low calorie diet on the clearance of oxazepam and antipyrine in man.
Sonne J; Dragsted J; Loft S; Døssing M; Andreasen F
Eur J Clin Pharmacol; 1989; 36(4):407-9. PubMed ID: 2737234
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine disposition in obesity.
Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Lean Liver Volume as a Potential Scaler for
Sinha J; Duffull SB; Green B; Al-Sallami HS
Curr Drug Metab; 2020; 21(10):746-750. PubMed ID: 32410559
[TBL] [Abstract][Full Text] [Related]
8. Influence of oral contraceptive use and cigarette smoking, alone and together, on antipyrine pharmacokinetics.
Scavone JM; Greenblatt DJ; Abernethy DR; Luna BG; Harmatz JS; Shader RI
J Clin Pharmacol; 1997 May; 37(5):437-41. PubMed ID: 9156376
[TBL] [Abstract][Full Text] [Related]
9. Caffeine disposition in obesity.
Abernethy DR; Todd EL; Schwartz JB
Br J Clin Pharmacol; 1985 Jul; 20(1):61-6. PubMed ID: 4027137
[TBL] [Abstract][Full Text] [Related]
10. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
[TBL] [Abstract][Full Text] [Related]
11. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation.
Scavone JM; Greenblatt DJ; LeDuc BW; Blyden GT; Luna BG; Harmatz JS
Pharmacology; 1990; 40(2):77-84. PubMed ID: 2345775
[TBL] [Abstract][Full Text] [Related]
13. Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
Greenblatt DJ; Divoll MK; Abernethy DR; Ochs HR; Harmatz JS; Shader RI
Pharmacology; 1989; 38(5):327-34. PubMed ID: 2762375
[TBL] [Abstract][Full Text] [Related]
14. Physical exercise and improvement of liver oxidative metabolism in the elderly.
Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
[TBL] [Abstract][Full Text] [Related]
15. Impairment of antipyrine metabolism by low-dose oral contraceptive steroids.
Abernethy DR; Greenblatt DJ
Clin Pharmacol Ther; 1981 Jan; 29(1):106-10. PubMed ID: 7460468
[TBL] [Abstract][Full Text] [Related]
16. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
17. Disposition of antipyrine in African patients with Hodgkin's lymphoma.
Juma FD
Br J Clin Pharmacol; 1987 Dec; 24(6):809-11. PubMed ID: 3440100
[TBL] [Abstract][Full Text] [Related]
18. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
Reidenberg MM; Vesell ES
Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
[TBL] [Abstract][Full Text] [Related]
19. Obesity effects on nitrazepam disposition.
Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
[TBL] [Abstract][Full Text] [Related]
20. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
Soto Alvarez J; Alsar Ortiz MJ
Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
